Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1363067

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1363067

Gastroretentive Drug Delivery Systems Outsourcing Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others), By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Gastroretentive Drug Delivery Systems Outsourcing Market Growth & Trends:

The global gastroretentive drug delivery systems outsourcing market size is expected to reach USD 2.27 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 6.99% from 2023 to 2030. Rising focus on patient-centric solutions and growing outsourcing demand are some of the key factors driving market expansion. Furthermore, an increased focus on localized drug delivery is expected to boost market growth.

Gastroretentive drug delivery systems are indicated for localized drug delivery applications in the gastrointestinal tract. This is particularly true for disorders such as peptic ulcers, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD). Moreover, the use of advanced technologies such as nanotechnology, 3D printing, and digital health in gastroretentive drug delivery systems has been investigated in order to improve drug delivery accuracy, monitoring, and patient involvement.

The COVID-19 pandemic significantly impacted the market for gastroretentive drug delivery systems outsourcing. Many clinical trials were postponed or delayed as a result of lockdowns, travel restrictions, and patient recruitment issues. This hampered the development and testing of novel gastroretentive medication delivery systems. Moreover, the pandemic disrupted worldwide supply chains, disrupting the availability of raw materials and industrial components. This factor had an influence on the manufacturing and development of gastroretentive drug delivery systems.

Factors such as rising strategic initiatives in the form of new product launches, partnerships, mergers & acquisitions by key operating companies, and growing investments in R&D programs are other factors expected to boost market growth in the coming years. For instance, in November 2022, Lonza introduced a new capsule solution known as Capsugel Enprotect, designed for intestinal drug delivery. Unlike conventional capsules, this innovative design remains intact during stomach transit and only releases its contents in the intestine. Capsugel Enprotect is a coating-free capsule that could potentially simplify the drug manufacturing process by eliminating the need for additional capsule coating or sealing.

Gastroretentive Drug Delivery Systems Outsourcing Market Report Highlights:

  • Based on dosage form, the tablets segment accounted for the largest revenue share of over 38% in 2022. Tablets are a well-known and extensively used dosage type. Because of their adaptability, they can be used in various formulation methods, such as controlled release, sustained release, and targeted administration, making them ideal for gastroretentive drug delivery systems
  • The capsule segment is expected to account for a significant market share in the forecast period. Capsule technology developments, such as modulated release and specialized coatings, enable the development of more advanced gastroretentive compositions. These advancements may enhance the demand for outsourcing services centered on capsule-based medication delivery systems
  • North America captured the largest revenue share of over 47% in 2022. This is attributed to the region's advanced pharmaceutical industry, strong research and development capabilities, high market demand, and an established healthcare infrastructure
  • On the other hand, the Asia Pacific region is expected to contribute significantly to the market revenue in the coming years. Cost-effective outsourcing, government support and incentives, rising healthcare needs, and technological advancements are some of the major factors driving the regional market growth
Product Code: GVR-4-68040-122-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Dosage Form Business Analysis

  • 4.1. Gastroretentive Drug Delivery Systems Outsourcing: Dosage Form Movement Analysis, 2022 & 2030
  • 4.2. Tablets
    • 4.2.1. Tablets Market, 2018 - 2030 (USD Million)
  • 4.3. Liquid
    • 4.3.1. Liquid Market, 2018 - 2030 (USD Million)
  • 4.4. Microspheres
    • 4.4.1. Microspheres Market, 2018 - 2030 (USD Million)
  • 4.5. Capsule
    • 4.5.1. Capsule Market, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Regional Market Snapshot
  • 5.2. North America
    • 5.2.1. North America Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.2.2.2. Key Country Dynamics
      • 5.2.2.3. Regulatory Framework
      • 5.2.2.4. Competitive Scenario
    • 5.2.3. Canada
      • 5.2.3.1. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.2.3.2. Key Country Dynamics
      • 5.2.3.3. Regulatory Framework
      • 5.2.3.4. Competitive Scenario
  • 5.3. Europe
    • 5.3.1. Europe Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.3.2. Germany
      • 5.3.2.1. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.2.2. Key Country Dynamics
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. Competitive Scenario
    • 5.3.3. UK
      • 5.3.3.1. UK Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.3.2. Key Country Dynamics
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Competitive Scenario
    • 5.3.4. France
      • 5.3.4.1. France Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.4.2. Key Country Dynamics
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Competitive Scenario
    • 5.3.5. Italy
      • 5.3.5.1. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.5.2. Key Country Dynamics
      • 5.3.5.3. Regulatory Framework
      • 5.3.5.4. Competitive Scenario
    • 5.3.6. Spain
      • 5.3.6.1. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.6.2. Key Country Dynamics
      • 5.3.6.3. Regulatory Framework
      • 5.3.6.4. Competitive Scenario
    • 5.3.7. Denmark
      • 5.3.7.1. Denmark Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.7.2. Key Country Dynamics
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Competitive Scenario
    • 5.3.8. Sweden
      • 5.3.8.1. Sweden Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.8.2. Key Country Dynamics
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Competitive Scenario
    • 5.3.9. Norway
      • 5.3.9.1. Norway Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.9.2. Key Country Dynamics
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Competitive Scenario
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.2.2. Key Country Dynamics
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. Competitive Scenario
    • 5.4.3. China
      • 5.4.3.1. China Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.3.2. Key Country Dynamics
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Competitive Scenario
    • 5.4.4. India
      • 5.4.4.1. India Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.4.2. Key Country Dynamics
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Competitive Scenario
    • 5.4.5. South Korea
      • 5.4.5.1. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.5.2. Key Country Dynamics
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Competitive Scenario
    • 5.4.6. Australia
      • 5.4.6.1. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.6.2. Key Country Dynamics
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Competitive Scenario
    • 5.4.7. Thailand
      • 5.4.7.1. Thailand Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.7.2. Key Country Dynamics
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Competitive Scenario
  • 5.5. Latin America
    • 5.5.1. Latin America Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.5.2. Key Country Dynamics
    • 5.5.3. Regulatory Framework
    • 5.5.4. Competitive Scenario
    • 5.5.5. Brazil
      • 5.5.5.1. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.5.5.2. Key Country Dynamics
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. Competitive Scenario
    • 5.5.6. Mexico
      • 5.5.6.1. Mexico Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.5.6.2. Key Country Dynamics
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Competitive Scenario
    • 5.5.7. Argentina
      • 5.5.7.1. Argentina Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.5.7.2. Key Country Dynamics
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. Competitive Scenario
  • 5.6. MEA
    • 5.6.1. MEA Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. South Africa Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.2.2. Key Country Dynamics
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Competitive Scenario
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.3.2. Key Country Dynamics
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Competitive Scenario
    • 5.6.4. UAE
      • 5.6.4.1. UAE Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.4.2. Key Country Dynamics
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Competitive Scenario
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.5.2. Key Country Dynamics
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Competitive Scenario

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
    • 6.2.1. Acquisitions
    • 6.2.2. Collaborations
    • 6.2.3. New Platform Launches
    • 6.2.4. Others
  • 6.3. Company Profiles/Listing
    • 6.3.1. Catalent
      • 6.3.1.1. Company Overview
      • 6.3.1.2. Financial Performance
      • 6.3.1.3. Platform Benchmarking
      • 6.3.1.4. Strategic Initiatives
    • 6.3.2. Lonza
      • 6.3.2.1. Company Overview
      • 6.3.2.2. Financial Performance
      • 6.3.2.3. Platform Benchmarking
      • 6.3.2.4. Strategic Initiatives
    • 6.3.3. Evonik
      • 6.3.3.1. Company Overview
      • 6.3.3.2. Financial Performance
      • 6.3.3.3. Platform Benchmarking
      • 6.3.3.4. Strategic Initiatives
    • 6.3.4. Colorcon
      • 6.3.4.1. Company Overview
      • 6.3.4.2. Financial Performance
      • 6.3.4.3. Platform Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Quotient Sciences
      • 6.3.5.1. Company Overview
      • 6.3.5.2. Financial Performance
      • 6.3.5.3. Platform Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. Aptar Pharma
      • 6.3.6.1. Company Overview
      • 6.3.6.2. Financial Performance
      • 6.3.6.3. Platform Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Aenova Group
      • 6.3.7.1. Company Overview
      • 6.3.7.2. Financial Performance
      • 6.3.7.3. Platform Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Evotec
      • 6.3.8.1. Company Overview
      • 6.3.8.2. Financial Performance
      • 6.3.8.3. Platform Benchmarking
      • 6.3.8.4. Strategic Initiatives
    • 6.3.9. Ashland
      • 6.3.9.1. Company Overview
      • 6.3.9.2. Financial Performance
      • 6.3.9.3. Platform Benchmarking
      • 6.3.9.4. Strategic Initiatives
    • 6.3.10. Vectura Group Ltd.
      • 6.3.10.1. Company Overview
      • 6.3.10.2. Financial Performance
      • 6.3.10.3. Platform Benchmarking
      • 6.3.10.4. Strategic Initiatives
Product Code: GVR-4-68040-122-6

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 4 Global Gastroretentive Drug Delivery Systems Outsourcing Market by Region, 2018 - 2030 (USD Million)
  • Table 5 North America Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 6 North America Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 7 U.S. Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 8 Canada Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 9 Europe Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 10 Europe Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 11 Germany Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 12 UK Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 13 France Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 14 Italy Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 15 Spain Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 16 Denmark Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 17 Sweden Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 18 Norway Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 21 China Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 22 Japan Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 23 India Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 24 South Korea Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 25 Australia Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 26 Thailand Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 27 Latin America Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 28 Latin America Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 29 Brazil Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 30 Mexico Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 31 Argentina Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 34 South Africa Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 36 UAE Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 37 Kuwait Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Gastroretentive Drug Delivery Systems Outsourcing Market, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Tablets,2018 - 2030 (USD Million)
  • Fig. 16 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Liquid,2018 - 2030 (USD Million)
  • Fig. 17 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Microspheres,2018 - 2030 (USD Million)
  • Fig. 18 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Capsule,2018 - 2030 (USD Million)
  • Fig. 19 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Others,2018 - 2030 (USD Million)
  • Fig. 20 Regional Outlook, 2021 & 2030
  • Fig. 21 North America Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 23 Canada Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 24 Europe Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 25 Germany Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 26 UK Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 27 France Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 28 Italy Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 29 Spain Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 30 Denmark Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 31 Sweden Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 32 Norway Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 33 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 34 Japan Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 35 China Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 36 India Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 37 Australia Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 38 South Korea Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 39 Thailand Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 40 Latin America Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 41 Brazil Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 43 Argentina Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 44 Middle East and Africa Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 45 South Africa Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 46 Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 47 UAE Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 48 Kuwait Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!